does injection site matter for semaglutide Sites: Abdomen vs. Thigh – Which Is Better? Where to inject for MAXIMUM

For semaglutide, the earliest realistic timeline for generic injectable entry: 2029: Generic manufacturers begin bioequivalence studies (2 years before the 2031 method-of-use patent expiration) 2030: ANDA submissions filed 2031-2032: FDA approvals granted, market entry Generic oral semaglutide could follow a faster timeline because Teva's Paragraph IV strategy (using a different absorption enhancer) avoids the SNAC patent entirely: 2026: Teva completes bioequivalence studies (already done as of April 2026) 2026: ANDA submission 2027: FDA approval, market entry The gap between patent expiration and market entry is why patients should not expect immediate cost relief when patents expire

It's frustrating, and it's avoidable

He received his Ph.D

it's about nutritional adequacy and optimization

The CARS is a 15-item clinician-rated behavioural scale that integrates caregiver reports with direct clinical observation

16 Thus, the decision to discontinue must be individualized and supported long term through continuity of care and multidisciplinary efforts that include referrals to nutrition, mental health, and exercise services